Early Cost Effectiveness of Whole-Genome Sequencing as a Clinical Diagnostic Test for Patients with Inoperable Stage IIIB,C/IV Non-squamous Non-small-Cell Lung CancerMartijn Simons, Manuela Joore|PharmacoEconomics|2021Cited by 34